SELLAS Life Sciences SLS
NASDAQ SLS
$11.54 +0.19 (+1.67%)
At close: Oct 23, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Cash & Current Investments (2010 - 2026)

Updated

SELLAS Life Sciences (SLS) posted Cash & Current Investments of $138.34 million for Q2 2026, up 446.8% from $25.3 million a year earlier and up 29.2% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, SELLAS Life Sciences' Cash & Current Investments came in at $71.79 million, up 417.0% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 15.3% (FY2020 to FY2025).
  • In prior years, SELLAS Life Sciences' Cash & Current Investments was $13.89 million in FY2024 (+448.9%), $2.53 million in FY2023 (-85.2%), $17.13 million in FY2022 (-19.8%) and $21.36 million in FY2021 (-39.5%).
  • The Q2 2026 figure stands as the highest quarterly Cash & Current Investments in data going back to Q2 2010.
  • On a year-over-year basis, Cash & Current Investments has increased in each of the last eight quarters, with growth averaging 294.6% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2024, with growth of 448.9%; the weakest was Q4 2023, with a decline of 85.2%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $107.1 million (Q1 2026), $71.79 million (Q4 2025) and $44.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 SELLAS Life Sciences 2.18 Bn 1.82 Bn - 138.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 138.34 Mn
Mar 31, 2026 107.10 Mn
Dec 31, 2025 71.79 Mn
Sep 30, 2025 44.32 Mn
Jun 30, 2025 25.30 Mn
Mar 31, 2025 28.40 Mn
Dec 31, 2024 13.89 Mn
Sep 30, 2024 21.03 Mn
Jun 30, 2024 9.15 Mn
Mar 31, 2024 18.42 Mn
Dec 31, 2023 2.53 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 13.81 Mn
Mar 31, 2023 23.90 Mn
Dec 31, 2022 17.13 Mn
Sep 30, 2022 21.35 Mn
Jun 30, 2022 27.00 Mn
Mar 31, 2022 14.30 Mn
Dec 31, 2021 21.36 Mn
Sep 30, 2021 26.30 Mn
API Access

SELLAS Life Sciences Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SLS&period=max&api_key=YOUR_API_KEY